Risks and limits of IgE Allergie Training

The term 'IgE allergy training' is not a standardized medical term and is often used in marketing contexts. It usually refers to specific immunotherapy (SIT, hyposensitization) for IgE-mediated allergies (e.g., pollen, dust mites). This therapy is well-evidenced for certain allergens (evidence: human-strong), but not for all IgE elevations. Risks include local reactions, rare systemic reactions, and anaphylaxis. Efficacy depends strongly on allergen type, application form (subcutaneous vs. sublingual), and adherence. 'Training' in the sense of arbitrarily reducing IgE through supplements or diets is not scientifically supported. Without proper medical diagnosis and indication, such measures can be dangerous. Limitations include the lack of standardization of the term, limited evidence for many allergens, and individual variability of immune response. Conservative assessment: Without specific study data from the context, the evidence is unclear.